250 Participants Needed

Behavioral Intervention for Type 1 Diabetes

(EMPoWER Trial)

MH
Overseen ByMarisa Hilliard, PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Baylor College of Medicine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The EMPoWER Study randomized clinical trial is a strengths-based behavioral intervention delivered to youth with type 1 diabetes (age 10 to 13) and their parents. The purpose of the intervention is to improve glycemic, behavioral, and psychosocial outcomes in youth with diabetes using a multiple systems approach that engages youth, their parents, and diabetes care providers to identify and build youths' diabetes strengths. The primary aim of this study is to assess the intervention impact on glycemic control, adherence, and health-related quality of life (HRQOL). Secondary aims are to evaluate behavioral mediators of intervention impact and to examine intervention dose as a mediator of intervention impact.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on behavioral interventions rather than medication changes.

Is the behavioral intervention for Type 1 Diabetes safe for humans?

The use of educational videos and mobile technology for diabetes management has been generally well-received, with positive feedback from participants and no reported safety concerns in the studies reviewed.12345

How is the behavioral intervention treatment for Type 1 Diabetes different from other treatments?

This behavioral intervention is unique because it focuses on teaching self-management skills and promoting adherence to diabetes care through psychological and educational support, rather than relying solely on medication. It often involves family participation and may use technology like mobile apps to engage adolescents, making it different from traditional medical treatments that focus on insulin and blood sugar control.16789

What data supports the effectiveness of the treatment Teen Videos, Behavioral Intervention Videos, Educational Videos for Type 1 Diabetes?

Research shows that educational and behavioral interventions can help improve diabetes knowledge and self-care in children and adolescents with type 1 diabetes. Behavioral interventions, especially those involving coping skills and peer support, have been found to assist adolescents in better managing their condition.1671011

Who Is on the Research Team?

MH

Marisa Hilliard, PhD

Principal Investigator

Baylor College of Medicine

Are You a Good Fit for This Trial?

This trial is for English-speaking teens aged 14-17 living in the US with type 1 diabetes for at least a year. It's not suitable for those with major psychiatric or developmental disorders, or serious medical conditions like cancer or cystic fibrosis.

Inclusion Criteria

Living in the United States
I have had type 1 diabetes for at least a year.
I am between 14 and 17 years old.
See 1 more

Exclusion Criteria

I do not have major health issues like cancer or cystic fibrosis.
I do not have any major psychiatric or developmental disorders that would affect my ability to consent or participate.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Orientation and Randomization

Parent-youth dyads complete an orientation session and are randomized to their study arm

1 week
1 visit (in-person or virtual)

Intervention

Participants engage in the T1DW Program or EUC Program for 6 months, involving app-based activities or monthly handouts

6 months
Monthly activities (virtual)

Follow-up

Participants are monitored for safety and effectiveness after the intervention, including satisfaction surveys and other assessments

6 months
3 visits (in-person or virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Teen Videos
Trial Overview The EMPoWER study is creating and testing teen-focused videos as part of a new behavioral intervention to help young people manage type 1 diabetes effectively alongside their parents.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Type 1 Doing Well (T1DW) ProgramExperimental Treatment1 Intervention
Group II: Diabetes-Related Information and Resources Program (Enhanced Usual Care; EUC)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor College of Medicine

Lead Sponsor

Trials
1,044
Recruited
6,031,000+

Children's National Research Institute

Collaborator

Trials
227
Recruited
258,000+

Published Research Related to This Trial

Educational interventions for children with type 1 diabetes effectively improve diabetes knowledge but do not consistently lead to better metabolic control, based on a review of 41 studies published between 1980 and 1999.
Psychosocial interventions, particularly coping skills training and peer support, are beneficial for adolescents in improving their adjustment to diabetes and can sometimes enhance metabolic control, while family interventions help reduce conflicts between parents and children regarding diabetes management.
Interventions for children with diabetes and their families.Grey, M.[2019]
Psychologists play a crucial role in diabetes care teams by providing psychological and behavioral interventions that help youth with Type 1 and Type 2 diabetes manage their condition, improve their quality of life, and achieve better glycemic control.
The article highlights the importance of tailored interventions that consider individual and family needs, and emphasizes the need for integrating behavioral health into routine diabetes care to enhance the effectiveness of treatment for both Type 1 and Type 2 diabetes.
Evidence-based behavioral interventions to promote diabetes management in children, adolescents, and families.Hilliard, ME., Powell, PW., Anderson, BJ.[2022]
Behavioral interventions for adolescents with type 1 diabetes show a small- to medium-sized beneficial effect on diabetes management, with an overall mean effect size of 0.33 based on a systematic review of 35 studies, including 24 randomized control trials.
Interventions grounded in theoretical frameworks were significantly more effective than those without such foundations, highlighting the importance of a solid theoretical basis in designing effective diabetes management programs.
Behavioral interventions for adolescents with type 1 diabetes: how effective are they?Hampson, SE., Skinner, TC., Hart, J., et al.[2022]

Citations

Interventions for children with diabetes and their families. [2019]
Evidence-based behavioral interventions to promote diabetes management in children, adolescents, and families. [2022]
Behavioral interventions for adolescents with type 1 diabetes: how effective are they? [2022]
Using mobile technology to motivate adolescents with type 1 diabetes mellitus: A systematic review of recent literature. [2022]
Behavioral Programs for Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis. [2022]
Edutainment tools for initial education of type-1 diabetes mellitus: initial diabetes education with fun. [2022]
Outcomes That Matter to Teens With Type 1 Diabetes. [2018]
Clinical effectiveness of a brief educational intervention in Type 1 diabetes: results from the BITES (Brief Intervention in Type 1 diabetes, Education for Self-efficacy) trial. [2022]
The use of videos for diabetes patient education: A systematic review. [2023]
A structured therapeutic education program for children and adolescents with type 1 diabetes: an analysis of the efficacy of the "Pediatric Education for Diabetes" project. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Behavioral assessment and intervention in pediatric diabetes. [2007]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity